BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33528708)

  • 21. Hospice use and high-intensity care in men dying of prostate cancer.
    Bergman J; Saigal CS; Lorenz KA; Hanley J; Miller DC; Gore JL; Litwin MS;
    Arch Intern Med; 2011 Feb; 171(3):204-10. PubMed ID: 20937914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
    McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
    JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
    Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
    Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.
    Barnato AE; McClellan MB; Kagay CR; Garber AM
    Health Serv Res; 2004 Apr; 39(2):363-75. PubMed ID: 15032959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.
    Fukui N; Golabi P; Otgonsuren M; de Avila L; Bush H; Younossi ZM
    Aliment Pharmacol Ther; 2018 Mar; 47(5):680-688. PubMed ID: 29314093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospitalization of hospice patients with cancer.
    Cintron A; Hamel MB; Davis RB; Burns RB; Phillips RS; McCarthy EP
    J Palliat Med; 2003 Oct; 6(5):757-68. PubMed ID: 14622455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
    Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
    JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Medicare costs with the growth of hospice care in nursing homes.
    Gozalo P; Plotzke M; Mor V; Miller SC; Teno JM
    N Engl J Med; 2015 May; 372(19):1823-31. PubMed ID: 25946281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Zou WY; El-Serag HB; Sada YH; Temple SL; Sansgiry S; Kanwal F; Davila JA
    Dig Dis Sci; 2018 May; 63(5):1173-1181. PubMed ID: 29508165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rural-Urban Differences in Costs of End-of-Life Care for Elderly Cancer Patients in the United States.
    Wang H; Qiu F; Boilesen E; Nayar P; Lander L; Watkins K; Watanabe-Galloway S
    J Rural Health; 2016 Sep; 32(4):353-362. PubMed ID: 26586101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closing the Gap in Hospice Utilization for the Minority Medicare Population.
    Hughes MC; Vernon E
    Gerontol Geriatr Med; 2019; 5():2333721419855667. PubMed ID: 31276019
    [No Abstract]   [Full Text] [Related]  

  • 33. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
    Hung P; Hsu SH; Wang SY
    Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of age on Medicare expenditures and medical care in the last year of life.
    Levinsky NG; Yu W; Ash A; Moskowitz M; Gazelle G; Saynina O; Emanuel EJ
    JAMA; 2001 Sep; 286(11):1349-55. PubMed ID: 11560540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in Hospice Utilization and Length of Stay for Medicare Patients With Melanoma.
    Hutchinson RN; Lucas FL; Becker M; Wierman HR; Fairfield KM
    J Pain Symptom Manage; 2018 Apr; 55(4):1165-1172.e5. PubMed ID: 29247755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospice use and public expenditures at the end of life in assisted living residents in a Florida Medicaid waiver program.
    Meng H; Dobbs D; Wang S; Hyer K
    J Am Geriatr Soc; 2013 Oct; 61(10):1777-81. PubMed ID: 24117288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do rural elders have limited access to Medicare hospice services?
    Virnig BA; Moscovice IS; Durham SB; Casey MM
    J Am Geriatr Soc; 2004 May; 52(5):731-5. PubMed ID: 15086653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States.
    Karim MA; Ramezani M; Leroux T; Kum HC; Singal AG
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2327-2337.e9. PubMed ID: 36435358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicare program expenditures associated with hospice use.
    Campbell DE; Lynn J; Louis TA; Shugarman LR
    Ann Intern Med; 2004 Feb; 140(4):269-77. PubMed ID: 14970150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in patient demographics and expenditures among Medicare hospice providers.
    Banaszak-Holl J; Mor V
    Hosp J; 1996; 11(3):1-19. PubMed ID: 8920312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.